Evidence map›Paper›PMID 34931943›Full record

ArticleAJOB neuroscience

Context-Dependent Risk & Benefit Sensitivity Mediate Judgments About Cognitive Enhancement.

Kiante Fernandez, Roy Hamilton, Laura Cabrera, John Dominic Medaglia

Abstract read
In one paragraph

Article in AJOB neuroscience. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Evaluating Risk and Benefit Sensitivity for Cognitive Treatments.Journal of cognitive enhancement : towards the integration of theory and practice · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kiante FernandezOhio State University.
Roy HamiltonPerelman School of Medicine, University of Pennsylvania.
Laura CabreraPennsylvania State University.
John Dominic MedagliaDrexel University and Perelman School of Medicine, University of Pennsylvania.

Funding

Treating primary progressive aphasia and elucidating neurodegeneration in the language network using transcranial direct current stimulationR01AG059763 · NIA · UNIVERSITY OF PENNSYLVANIA · PI HAMILTON, ROY H · 2019 to 2024
$3.7M
Dynamic Network Neuroscience and Control Theory: Toward Interventions for Cognitive Control DysfunctionDP5OD021352 · OD · UNIVERSITY OF PENNSYLVANIA · PI MEDAGLIA, JOHN · 2015 to 2019
$2.0M
NIA NIH HHS R01 AG059763NIH HHS DP5 OD021352
6 · The paper itself

Abstract

Opinions about cognitive enhancement (CE) are context-dependent. Prior research has demonstrated that factors like peer pressure, the influence of authority figures, competition, moral relevance, familiarity with enhancement devices, expertise, and the domain of CE to be enhanced can influence opinions. The variability and malleability of patient, expert, and public attitudes toward CE is important to describe and predict because these attitudes can influence at-home, clinical, research, and regulatory decisions. If individual preferences vary, they could influence opinions about practices and regulations due to disagreements about the desirable levels of risks and benefits. The study of attitudes about CE would benefit from psychological theories that explain judgments. In particular, we suggest that variability in risk and benefit sensitivity could psychologically mediate judgments about CE in many contexts. Drawing from prospect theory, which originated in behavioral economics, it is likely that framing effects, shifted reference points, and the tendency to weigh losses (risks) more heavily than gains (benefits) predict decisions about CE. We suggest that public policy could benefit from a shared conceptual framework, such as prospect theory, that allows us to describe and predict real-world decisions about CE by patients, experts, and the public.

Indexed as

AttitudeJudgmentCognitionHumansMoralsRisk AssessmentCognitive enhancement; decision making; neuroethics

Identifiers

PMID34931943
PMCPMC9867800

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.